Embedded Files
Moderna, a Massachusetts-based vaccine developer, partnered with the National Institutes of Health to develop and test a coronavirus vaccine known as mRNA-1273. A clinical trial demonstrated that the vaccine has an efficacy rate of 94.1 percent in preventing Covid-19.
What do you think?
Take a look and learn: How Moderna’s Covid-19 Vaccine Works - The New York Times (nytimes.com)
Page updated
Google Sites
Report abuse